Ideas

January 8, 2019

Published by admin_auro at January 8, 2019

Categories

Ribonucleic acid-based therapy for Myocardial Infarction: LncRNA Hoxb-AS3 inhibits DNA damage responses, induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte survival after myocardial infarction, via up-regulation of PNUTS, 9/January/2019, 12.01 am

What they say: A recent study from the Institute for Cardiovascular Regeneration, Centre of Molecular Medicine, Frankfurt, Germany shows that “MicroRNA-34a regulates cardiac ageing and function.” This study was published, in the 7 March 2013 issue of of […]

January 8, 2019

Published by admin_auro at January 8, 2019

Categories

Probiotic-based therapy for TIIDM and obesity-associated metabolic deficits: Probiotic VSL#3 increases Lipocalin 2 (LCN2) expression, activates an MC4R-dependent anorexigenic pathway, suppresses appetite and weight gain, increases insulin secretion, improves glucose tolerance, promotes glucose homeostasis, improves obesity-associated metabolic deficits and prevents progression to TIIDM, via down-regulation of its target gene, 8/January/2019, 11.45 pm

Introduction: What they say A study from the Department of Physiology-Cellular Biophysics, College of Physicians and Surgeons, Columbia University, New York, New York, USA shows that “MC4R-dependent […]

January 8, 2019

Published by admin_auro at January 8, 2019

Categories

Repurposing the anti-hypertensive agent Isradipine into an anti-diabetic agent: Isradipine (Trade name:DynaCirc, Prescal), an antihypertensive agent, increases the expression of IGF1R, INSR, and IRS2, and promotes an insulin-sensitized state, via up-regulation of its target gene Lin28, 8/January/2018, 11.37 pm

Introduction: What they say: A study from the Stem Cell Transplantation Program, Division of Pediatric Hematology/Oncology, Boston Children’s Hospital and Dana-Farber Cancer Institute, Boston, Massachusetts, USA shows that “The Lin28/let-7 axis […]

January 8, 2019

Published by admin_auro at January 8, 2019

Categories

Ribonucleic acid-based therapy for glucose homeostasis and TIIDM: LncRNA MALAT1 increases Pax6 and insulin expression, decreases the levels of glucagon, ghrelin and Somatostatin, reduces metabolic stress, improves insulin sensitivity, promotes glucose homeostasis and prevents progression to TIIDM, via down regulation of its target gene, 8/January/2019, 11.08 pm

Introduction: What they say A study from the Department of Developmental Biology and Cancer Research, The Institute for Medical Research Israel-Canada, The Hebrew University-Hadassah Medical School, […]